Our mission is to promote excellence in clinical care, patient safety, multi-disciplinary team performance and research through the application of simulation and innovative technologies for education. We offer high-tech facilities, expert staff, and the most realistic training environment possible.
The New England Pediatric Device Consortium (NEPDC) is a non-profit foundation supported by the FDA’s Office of Orphan Products Development (OOPD) to promote commercialization of safe and effective technologies for pediatric clinical care. NEPDC accelerates commercialization by connecting innovators with …
Monthly and ad hoc blog posts on medical device and healthcare technology regulation and reimbursement/payment news.
Learn about the opportunity to explore commercial activities while retaining faculty status.
TREAT offers Pilot Project grants support the development and commercialization of novel rehabilitation and assistive technology ideas. Innovators from all professional backgrounds are encouraged to submit proposals for competitive review. Proposals typically focus on devices that address a clear rehabilitation …
We can provide introductions to experts that participant in the UVM SPARK panel and guidance on setting up a SPARK-type program at your institution.
Travel awards to the annual HHS annual SBIR/STTR meeting. This meeting is organized by the NIH SBIR program with the primary goal of attracting biomedical small businesses and training them in SBIR/STTR grant applications. The meeting provides training sessions covering …
This intensive biomedical entrepreneurship course is designed to bridge the gap between biomedical researchers and the mainstream customer by providing a practical understanding of what is required to bring products to the marketplace and the roadmap to get there. Held …
Applicants can select any Bioscience-based business or other business such as law offices or consultant firms that support the bioscience community to provide the applicants with the desired training.
The I-Trep program offers individual one-to-one consulting with experts to assist you with commercializing your innovation.
These 20 modules provide detailed readings, presentations, and worksheets for the milestones in TREAT’s Commercialization Methodology. This serves as a product development pathway, helping to create a road map and mitigate risk in bringing innovation from ideation to market.
The purpose of this course is to present biomedical entrepreneurs with a detailed framework for building a step-wise, validated financial plan.
Opportunity to schedule a free 30 minute session to discuss any aspect of your business or business idea with a group of seasoned entrepreneurs.
Become a successful business person. We help you (women and men) increase your professional success, personal growth, and financial independence.
The ECenter understands the importance of funding. Some ventures need an angel investor for a first round of outside capital or, depending upon the idea stage, you might be looking to a venture capital firm to raise a Series A …
YourEncore was founded in 2003 to act as a retiree return program for Lilly, P&G and Boeing. Over the past 14 years, we’ve grown and evolved into a flexible resourcing and consulting community, supporting hundreds of clients ranging from global …
Validated assays, specimen handling procedures, and reagent sources for clinical pharmacodynamic studies and Training Certification
Patient-derived models including patient-derived xenografts and in vivo patient-derived cell cultures annotated with clinical observations and molecular characterizations
Provides a focused consultation with NCI staff regarding the critical path considerations for developing novel investigational drugs intended for human use (i.e. small molecule or biologic, therapeutic or imaging drugs) and how to effectively communicate with the FDA.
Helps researchers identify potentially promising combinations of cancer drugs by providing data and analysis tools showing how well pairs of FDA-approved cancer drugs performed in killing tumor cells from the NCI-60 Human Tumor Cell Lines.
Navigator is a resource for investigators who have typically conducted exploratory correlative analysis and are now seeking specimens to validate their hypotheses.
This software provides an easy to use, fast compiled C program that runs in a DOS window for computing optimal and minimax two-stage designs for phase II clinical trials.
Through its Clinical and Translational Science Awards (CTSA) Program, NCATS is developing a single institutional review board (IRB) platform for multisite clinical studies: the NCATS Streamlined, Multisite, Accelerated Resources for Trials (SMART) IRB Platform. The goal is to provide flexible …
Knowing therapy development is a challenging process, NINDS asked its biologic consultant contractors to generate guidance documents to better prepare investigators.
Screening services, molecular targeting, drug development services